Monte Rosa Therapeutics
GLUE
#6712
Rank
โ‚ฌ0.67 B
Marketcap
7,88ย โ‚ฌ
Share price
-3.03%
Change (1 day)
-36.21%
Change (1 year)

Earnings for Monte Rosa Therapeutics (GLUE)

Earnings in 2026 (TTM): -โ‚ฌ0.12 Billion

According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are โ‚ฌ70.32 Million. In 2025 the company made an earning of -โ‚ฌ36.22 Million, an increase over its 2024 earnings that were of -โ‚ฌ63.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monte Rosa Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.12 Billion209.66%
2025 -โ‚ฌ36.22 Million-43.36%
2024 -โ‚ฌ63.94 Million-48.06%
2023 -โ‚ฌ0.13 Billion24.43%
2022 -โ‚ฌ98.91 Million46.71%
2021 -โ‚ฌ67.43 Million106.13%
2020 -โ‚ฌ32.71 Million